UC-II® Clinical Data Presented at FOCIS

BENICIA, Calif.Siba Raychaudhuri, M.D., UC Davis researcher, presented joint health research on Interhealth Nutraceutical's UC-II® at the Federation of Clinical Immunology Societies (FOCIS) 2010 meeting in Boston, June 24 to 27. Raychaudhuri is a rheumatologist at the Department of Medicine, University of California Davis, and also the corresponding author of a published clinical study demonstrating UC-IIs effectiveness over glucosamine + chondroitin. Raychaudhuris FOCIS presentation entitled, Undenatured Type II Collagen (UC-II) in the Treatment of Osteoarthritis addressed one of the hottest topics in the industry, joint-health support.

Raychaudhuri said: Not only is the clinical data on UC-II impressive, it also works in quite a unique way to inhibit joint cartilage damage, allowing the body to rebuild healthy joints. UC-II contains undentaured type II collagen, which reportedly aids in reducing the destruction of collagen within the joints, helps to reduce inflammation in the joints and improves joint flexibility.

Researchers and clinicians from around the world attend the FOCIS annual meeting to draw pertinent information and learn about new science and breakthroughs regarding human health and to share expertise to build a better and faster understanding on various ways to address inflammatory and autoimmune diseases.